Pharmacology In Drug Discovery And Development |link| -

In 2006, this CD28 superagonist caused catastrophic multi-organ failure in six healthy volunteers within hours. The failure was . Preclinical studies in cynomolgus monkeys used a different CD28 expression profile on T-cells. Human T-cells were hyper-responsive. Outcome: New era of in vitro human cell-based assays (e.g., using human peripheral blood mononuclear cells) before FIH trials.

The journey begins not with a drug, but with a hypothesis. Pharmacologists work alongside geneticists and molecular biologists to validate a target. Once a target is identified (e.g., a specific kinase driving cancer growth), the search for a "lead compound" begins. pharmacology in drug discovery and development

Before any substance is tested in humans, its pharmacological profile must be rigorously established in laboratory and animal models. Asian Journal of Pharmacy and Technology Human T-cells were hyper-responsive

Here, pharmacology ensures the drug behaves consistently across thousands of diverse patients. modeling is used to understand why a 70kg male and a 50kg female may need different doses. Exposure-Response analysis determines if higher plasma levels lead to more cures or more deaths. a specific kinase driving cancer growth)

PK is where most "hits" die. Pharmacologists work hand-in-hand with medicinal chemists in an iterative cycle called .

The journey doesn't end when the drug hits the pharmacy shelf.